Abolfazl Heidari
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
-
- Genomics and Rare Diseases 2
- Genetics and Neurodevelopmental Disorders 2
- Genetic Syndromes and Imprinting 1
-
- Signaling Pathways in Disease 2
- Ion channel regulation and function 1
- Mitochondrial Function and Pathology 1
-
- Caveolin-1 and cellular processes 2
- Co-authors
- Golaleh AsghariMitra HasheminiaParvin MirmiranKamran GuityMohammad Karim ShahrzadFarzad HadaeghFereidoun AziziMohammad Keramatipour
- Journals
- Diabetology & Metabolic Syndrome (1 paper)European Neuropsychopharmacology (1 paper)Journal of Molecular Neuroscience (1 paper)
- Partner nations
- IranCanadaSaudi Arabia
In The Last Decade
Abolfazl Heidari
6 papers receiving 59 citations
Peers
Comparison fields: 5 of 40
- Endocrinology, Diabetes and Metabolism 12
- Health Information Management 3
- Immunology 10
- Genetics 13
- Cellular and Molecular Neuroscience 6
Countries citing papers authored by Abolfazl Heidari
This map shows the geographic impact of Abolfazl Heidari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abolfazl Heidari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abolfazl Heidari more than expected).
Fields of papers citing papers by Abolfazl Heidari
This network shows the impact of papers produced by Abolfazl Heidari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abolfazl Heidari. The network helps show where Abolfazl Heidari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abolfazl Heidari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2021 | 24 | |
| 3 | 2021 | 1 | |
| 4 | 2019 | 0 | |
| 5 | 2019 | 0 | |
| 6 | 2014 | 3 | |
| 7 | 2013 | 19 | |
| 8 | CTLA-4 gene polymorphisms (-318C/T, +49A/G, +6230A/G) in Iranian patients with multiple sclerosis. | 2010 | 11 |
About Abolfazl Heidari
Abolfazl Heidari is a scholar working on Clinical Biochemistry, Genetics and Cell Biology, having authored 8 papers that have together received 59 indexed citations. Recurring topics across this work include Genomics and Rare Diseases (2 papers), Signaling Pathways in Disease (2 papers), Genetics and Neurodevelopmental Disorders (2 papers), Caveolin-1 and cellular processes (2 papers), Genetic Syndromes and Imprinting (1 paper), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Ion channel regulation and function (1 paper) and Mitochondrial Function and Pathology (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (12 citations), Health Information Management (3 citations) and Immunology (10 citations). Abolfazl Heidari has collaborated with scholars based in Iran, Canada and Saudi Arabia. Frequent co-authors include Golaleh Asghari, Mitra Hasheminia, Parvin Mirmiran, Kamran Guity, Mohammad Karim Shahrzad, Farzad Hadaegh, Fereidoun Azizi, Mohammad Keramatipour, Mina Ohadi and Mansoureh Togha. Their work appears in journals such as Diabetology & Metabolic Syndrome, European Neuropsychopharmacology, Journal of Molecular Neuroscience, Current Research in Translational Medicine and Journal of Clinical Research in Pediatric Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.